Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.

  1. Next Generation Portable Power Amplifier

    SBC: MAXENTRIC TECHNOLOGIES, LLC            Topic: SOCOM13004

    MaXentric proposes the GAU2x2 wideband power amplifier system. The design combines MaXentrics wideband RF PA technology with advanced digital signal processing in a single small footprint package. This tight integration is made possible through the extremely high efficiency and low power dissipation. Since very little power is dissipated as heat, the package and heat sink size can be minimized. In ...

    SBIR Phase II 2019 Department of DefenseSpecial Operations Command
  2. SBIR Phase II: Development of a Stoichiometric, Direct-Injected, Soot-Free Engine for Heavy-Duty Applications

    SBC: ClearFlame Engines, Inc.            Topic: MN

    Diesel engines remain critical to global economies, but are under threat from increasingly-stringent emissions regulations. Many alternatives, like spark-ignition and electric vehicles, sacrifice some of the performance or range benefits of Diesel-style operation. This creates a market need for technologies that can maintain Diesel engine performance while remaining decoupled from the dirty emissi ...

    SBIR Phase II 2019 National Science Foundation
  3. SBIR Phase II: Hydro-financial modeling architecture for the automated optimization of low basis risk indices

    SBC: LOTIC LABS LLC            Topic: IT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will result from improved financial resilience of hundreds of thousands of water-dependent businesses and municipalities currently threatened by hydrologic volatility and severely strained ecosystems. This SBIR research will enable the seamless integration of scientific and financial modeling ...

    SBIR Phase II 2019 National Science Foundation
  4. SBIR Phase II: Carbon Nanotube Enhanced Membrane Distillation for Sea and Brackish Water Desalination, and the Treatment of Saline Waste Water

    SBC: Nanosepex Inc.            Topic: CT

    The broader impact/commercial potential of this Small Business Innovative Research (SBIR) project arises from addressing one of the world's major challenges - the need for water. We address this problem through the development of a novel technology for economic desalting for inexpensive clean water generation and the treatment of high concentration saline waste. There is no "one size fits all" app ...

    SBIR Phase II 2019 National Science Foundation
  5. SBIR Phase II: Digitization of Skeletal Evaluations for Developmental and Reproductive Toxicology (DART) Studies.

    SBC: Visikol, Inc.            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be the development of technology to improve the accuracy of skeletal evaluation within developmental and reproductive toxicology (DART) studies. The goal is to better ensure that potential therapeutics, cosmetics and agrochemicals do not cause teratogenic effects. Today, DART studies rel ...

    SBIR Phase II 2019 National Science Foundation
  6. SBIR Phase II: Aggressive Maneuvering of Small Autonomous Robots in Home Environments

    SBC: Petronics Inc.            Topic: EW

    The broader impact/commercial potential of this project is to enable mobile robots to coexist harmoniously with people in their homes and offices. The market for consumer and office robots is projected to grow 17% annually, seven times faster than the market for manufacturing robots, reaching $1.5B by 2019. An important step toward market growth is creating autonomous robots that are unobtrusive, ...

    SBIR Phase II 2018 National Science Foundation
  7. SBIR Phase II: A Clinical Decision Support System for Fluid Resuscitation of Intensive Care Unit Patients

    SBC: Autonomous Healthcare Inc            Topic: SH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project involves addressing complexities in fluid management, one of the most important issues in critical care. Suboptimal fluid management results in many complications such as pulmonary edema. Studies show that fluid overload is associated with higher rates of morbidity and mortality. Recent studi ...

    SBIR Phase II 2018 National Science Foundation
  8. SBIR Phase II: Efficient Custom Machine Learning for Embedded Intelligence in the Internet of Things

    SBC: Inspirit Iot, Inc.            Topic: I

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will result in a significant improvement in the performance, power, and cost of deploying machine learning (ML) solutions through horizontal platform technologies that enable many vertical applications. This improvement will accelerate deployment of intelligent systems and improve scalability ...

    SBIR Phase II 2018 National Science Foundation
  9. SBIR Phase II: X-Ray Focusing Device for 20-100 keV Photon Energies

    SBC: Alcorix Co.            Topic: MI

    This Small Business Innovation Research Phase II project targets the fabrication of devices capable of focusing X-rays with high energy (from 10 keV to above 100 keV) to spot sizes as small as 7 nanometers. This capability is critical for imaging, microtomography, and elemental and structural analyses of materials and will permit imaging in spectral ranges and at resolutions unavailable today. The ...

    SBIR Phase II 2018 National Science Foundation
  10. SBIR Phase II: Point of Care Device for High Frequency Stratification of Patient Populations at Risk of Sepsis

    SBC: Prenosis, Inc.            Topic: BM

    Sepsis is a poorly understood clinical syndrome and is characterized by a dysregulation of the immune system?s response to infection. It is the leading cause of death and is the most expensive condition treated in U.S. hospitals, exerting a $20.3 billion burden annually, 5.2% of total costs to the healthcare system nationwide. Sepsis is highly time critical and every 1-hour delay in antibiotics is ...

    SBIR Phase II 2018 National Science Foundation
US Flag An Official Website of the United States Government